Redox-responsive polymer-drug conjugates based on doxorubicin and chitosan oligosaccharide-g-stearic acid for cancer therapy.

Here, a biodegradable polymer-drug conjugate of doxorubicin (DOX) conjugated with a stearic acid-grafted chitosan oligosaccharide (CSO-SA) was synthesized via disulfide linkers. The obtained polymer-drug conjugate DOX-SS-CSO-SA could self-assemble into nanosized micelles in aqueous medium with a low critical micelle concentration. The size of the micelles was 62.8 nm with a narrow size distribution. In reducing environments, the DOX-SS-CSO-SA could rapidly disassemble result from the cleavage of the disulfide linkers and release the DOX. DOX-SS-CSO-SA had high efficiency for cellular uptake and rapidly released DOX in reductive intracellular environments. In vitro antitumor activity tests showed that the DOX-SS-CSO-SA had higher cytotoxicity against DOX-resistant cells than free DOX, with reversal ability up to 34.8-fold. DOX-SS-CSO-SA altered the drug distribution in vivo, which showed selectively accumulation in tumor and reduced nonspecific accumulation in hearts. In vivo antitumor studies demonstrated that DOX-SS-CSO-SA showed efficient suppression on tumor growth and relieved the DOX-induced cardiac injury. Therefore, DOX-SS-CSO-SA is a potential drug delivery system for safe and effective cancer therapy.

[1]  James B. Mitchell,et al.  Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels. , 2002, Cancer research.

[2]  Chun Xing Li,et al.  Specific tumor delivery of paclitaxel using glycolipid-like polymer micelles containing gold nanospheres. , 2013, Biomaterials.

[3]  H. Hamana,et al.  Synthesis of carboxymethylpullulan-peptide-doxorubicin conjugates and their properties. , 1995, Chemical & pharmaceutical bulletin.

[4]  A J Sinskey,et al.  Oxidized redox state of glutathione in the endoplasmic reticulum. , 1992, Science.

[5]  G. Hart,et al.  Nuclear pore complex glycoproteins contain cytoplasmically disposed O- linked N-acetylglucosamine , 1987, The Journal of cell biology.

[6]  T. Okano,et al.  Process design for efficient and controlled drug incorporation into polymeric micelle carrier systems. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[7]  Yan Xia,et al.  Drug-loaded, bivalent-bottle-brush polymers by graft-through ROMP. , 2010, Macromolecules.

[8]  K. Ulbrich,et al.  Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin. , 2010, Biomaterials.

[9]  Kazuo Tanaka,et al.  Heavy metal-free 19F NMR probes for quantitative measurements of glutathione reductase activity using silica nanoparticles as a signal quencher. , 2012, Bioorganic & Medicinal Chemistry.

[10]  S. Santra,et al.  Cell-specific, activatable, and theranostic prodrug for dual-targeted cancer imaging and therapy. , 2011, Journal of the American Chemical Society.

[11]  S. Zeng,et al.  A novel chitosan oligosaccharide-stearic acid micelles for gene delivery: properties and in vitro transfection studies. , 2006, International journal of pharmaceutics.

[12]  S. Kannan,et al.  Poly(amidoamine) dendrimer-drug conjugates with disulfide linkages for intracellular drug delivery. , 2009, Biomaterials.

[13]  Duxin Sun,et al.  Superparamagnetic iron oxide nanotheranostics for targeted cancer cell imaging and pH-dependent intracellular drug release. , 2010, Molecular pharmaceutics.

[14]  Hong Yuan,et al.  Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles. , 2009, Biomaterials.

[15]  Chulhun Kang,et al.  Disulfide-cleavage-triggered chemosensors and their biological applications. , 2013, Chemical reviews.

[16]  G. Takemura,et al.  Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management. , 2007, Progress in cardiovascular diseases.

[17]  R. Freidinger,et al.  The synthesis of a prodrug of doxorubicin designed to provide reduced systemic toxicity and greater target efficacy. , 2001, Journal of medicinal chemistry.

[18]  Xing Guo,et al.  pH-triggered intracellular release from actively targeting polymer micelles. , 2013, Biomaterials.

[19]  S. Kannan,et al.  Stimuli-responsive star poly(ethylene glycol) drug conjugates for improved intracellular delivery of the drug in neuroinflammation. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[20]  P. Couvreur,et al.  Prodrug-based intracellular delivery of anticancer agents. , 2011, Advanced drug delivery reviews.

[21]  K. Ulbrich,et al.  Biodegradable star HPMA polymer-drug conjugates: Biodegradability, distribution and anti-tumor efficacy. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[22]  C. Tung,et al.  Proteolysis: a biological process adapted in drug delivery, therapy, and imaging. , 2009, Bioconjugate chemistry.

[23]  Felix Kratz,et al.  Polymer therapeutics: concepts and applications. , 2006, Angewandte Chemie.

[24]  Yiyu Cheng,et al.  Quantitative study of the drug efflux kinetics from sensitive and MDR human breast cancer cells. , 2007, Biochimica et biophysica acta.

[25]  J. Ljubimova,et al.  Nanomedicine therapeutic approaches to overcome cancer drug resistance. , 2013, Advanced drug delivery reviews.

[26]  Hong Yuan,et al.  Coadministration of glycolipid-like micelles loading cytotoxic drug with different action site for efficient cancer chemotherapy , 2009, Nanotechnology.

[27]  Hong Yuan,et al.  Effect of proteins with different isoelectric points on the gene transfection efficiency mediated by stearic acid grafted chitosan oligosaccharide micelles. , 2013, Molecular pharmaceutics.

[28]  Jianping Zhou,et al.  Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel. , 2012, Biomaterials.

[29]  S. Zeng,et al.  Shell cross-linked stearic acid grafted chitosan oligosaccharide self-aggregated micelles for controlled release of paclitaxel. , 2006, Colloids and surfaces. B, Biointerfaces.

[30]  Jayant Khandare,et al.  Polymer-drug conjugates: Progress in polymeric prodrugs , 2006 .

[31]  R. Weissleder,et al.  Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging , 2002, European Radiology.

[32]  I. Kwon,et al.  Preparation of chitosan self-aggregates as a gene delivery system. , 1998, Journal of controlled release : official journal of the Controlled Release Society.